Trademarkia Logo

Canada

C$
Trademark Search in Canada
BLUEROCK

View On IC.GC.CA

BLUEROCK
REGISTERED

on 22 Sept 2021

Last Applicant/ Owned by

BLUEROCK THERAPEUTICS LP

1 BroadwayFloor FifteenCambridge, Massachusetts 02142

US

Serial Number

1854001 filed on 23rd Aug 2017

Registration Number

TMA1110064 registered on 22nd Sept 2021

Registration expiry Date

22nd Sept 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

BLUEROCK

Trademark usage description

chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, includi Read More

Classification Information

Class [001]
Chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of body cells and cells of the immune system of mammals, including human cells; diagnostic preparations for medical-scientific research use; combinations of cells and materials in the nature of cell culture media for laboratory use, namely, reagents, nucleotides, carrier proteins, encapsulation materials, engineered matrix, diagnostic preparations, scaffolds, polymers, tracers, dyes, hydrogels, activating agents, detergents, stabilizers, emulsifiers, oxidants, antioxidants, vitamins, salts, sugars, amino acids, buffers, nucleic acids and viral vectors for biological scientific and research use;

Classification kind code

11

Class [005]
Therapeutic cells derived from stem cells for medical and clinical laboratory use; kits comprised of cells and pharmaceuticals, namely antibacterial gels, antivirals, antifungals medications, anti-inflammatories, and pharmaceutical preparations for regulating the immune system, for medical and clinical laboratory use; pharmaceutical preparations for use in therapeutics for the treatment of liver, gall bladder, pancreas, gastrointestinal, menopausal, autoimmune, ophthalmologic, renal, aural, respiratory, hematologic, oncological, and ocular diseases and disorders; pharmaceutical preparations for use in therapeutics for the treatment of cardiovascular diseases and disorders, namely congestive heart failure, acute myocardial infarction, arrythmia, hypoplastic left heart syndrome, atrial fibrillation, peripheral artery disease, pulmonary arterial hypertension; pharmaceutical preparations for use in therapeutics for the treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system and peripheral nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders; pharmaceutical preparations for use in therapeutics for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for use in therapeutics for the treatment of immunologic diseases, namely, autoimmune diseases, immune response to grafts and transplants, autoimmune disorders, fibrosis disorders, Crohn's, Colitis, lupus, erythematosus (SLE), multiple sclerosis, neuromyelitis optica, type-1 diabetes, solid organ transplant, immunologic deficiency syndromes; pharmaceutical preparations for use in therapeutics for the treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, erosion, ulcer, trauma, burned skin, pain, inflammation, contagious skin diseases, dandruff, herpes, hives, hyperhidrosis, keloids, melanoma, rosacea, scleroderma, shingles, skin cancer, warts; pharmaceutical preparations for use in therapeutics for the treatment of infectious diseases, namely respiratory infections, asthma, bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema, lung cancer, pleural effusion, pneumonia, pulmonary fibrosis and sarcoidosis; pharmaceutical preparations for use in therapeutics for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, chickenpox, common cold, diphtheria, E. coli, Giardiasis, HIV/AIDS, infectious mononucleosis, influenza, Lyme disease, malaria, measles, meningitis, mumps, poliomyelitis, rocky mountain spotted fever, rubella, salmonella, severe acute respiratory syndrome (SARS), sexually transmitted diseases, shingles, tetanus, toxic shock syndrome, tuberculosis, viral hepatitis, West Nile virus, whooping cough; pharmaceutical preparations for use in therapeutics for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, lysosomal storage disorders, osteoarthritis, muscular dystrophy, anemia, acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repair-deficiency disorders, glucose metabolism disorders, hyperlactatemia, iron metabolism disorders, lipid metabolism disorders, malabsorption syndromes, metabolic syndrome X, inborn error of metabolism, mitochondrial diseases, phosphorus metabolism disorders, porphyrias, proteostasis deficiencies, metabolic skin diseases, wasting syndrome, water-electrolyte imbalance; pharmaceutical preparations for use in therapeutics for the treatment of musculoskeletal system, namely, connective tissue diseases and cartilage injuries; pharmaceutical preparations for use in therapeutics for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Parkinson's disease, tauopathies, Alzheimer's disease, frontotemporal dementias, acute injury such as traumatic brain injury, stroke, chronic neuroinflammation, epilepsy, transverse myelitis, neuromyelitis optica, leukodystrophies, multiple sclerosis, acute injury, cerebral palsy, Hirschsprung's disease, diabetic gastroparesis, glioblastoma, ALS, back pain, Bell's palsy, birth defects of the brain and spinal cord, brain aneurysm, brain tumor, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, Guillain-Barré syndrome, headache, migraine, neuralgia, neuromuscular and related diseases, namely, neuropathy, spinal deformity, spine tumor, vertigo; pharmaceutical preparations for use in therapeutics for the treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorder, depression, eating disorders, obsessive-compulsive disorder, panic disorder, personality disorders, post-traumatic stress disorder, psychotic disorders; pharmaceutical preparations for use in therapeutics for the treatment of sensory neural diseases and disorders, namely macular degeneration, glaucoma, diabetic retinopathy, auditory processing disorder, auditory verbal agnosia, neuropathic pain, hyperalgesia, phantom limb syndrome, nociceptor disorders; pharmaceutical preparations for use in therapeutics for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic disease; pharmaceutical preparations for use in therapeutics for the treatment of fungal skin infections and viral skin infections; pharmaceutical preparations for the treatment of liver, gall bladder, pancreas, central nervous system, endocrine, gastrointestinal, menopausal, autoimmune, ophthalmologic, renal, aural, respiratory, hematologic, diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, namely congestive heart failure, acute myocardial infarction, arrythmia, hypoplastic left heart syndrome, atrial fibrillation, peripheral artery disease, pulmonary arterial hypertension; pharmaceutical preparations for the treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system and peripheral nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immune response to grafts and transplants, autoimmune disorders, fibrosis disorders, Crohn's, Colitis, lupus, erythematosus (SLE), multiple sclerosis, neuromyelitis optica, type-1 diabetes, solid organ transplant, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, erosion, ulcer, trauma, burned skin, pain, inflammation, contagious skin diseases, dandruff, herpes, hives, hyperhidrosis, keloids, melanoma, rosacea, scleroderma, shingles, skin cancer, warts; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, namely asthma, bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema, lung cancer, pleural effusion, pneumonia, pulmonary fibrosis and sarcoidosis; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, chickenpox, common cold, diphtheria, E. coli, Giardiasis, HIV/AIDS, infectious mononucleosis, influenza, Lyme disease, malaria, measles, meningitis, mumps, poliomyelitis, rocky mountain spotted fever, rubella, salmonella, severe acute respiratory syndrome (SARS), sexually transmitted diseases, shingles, tetanus, toxic shock syndrome, tuberculosis, viral hepatitis, West Nile virus, whooping cough; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, lysosomal storage disorders, osteoarthritis, muscular dystrophy, anemia, acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repair-deficiency disorders, glucose metabolism disorders, hyperlactatemia, iron metabolism disorders, lipid metabolism disorders, malabsorption syndromes, metabolic syndrome X, inborn error of metabolism, mitochondrial diseases, phosphorus metabolism disorders, porphyrias, proteostasis deficiencies, metabolic skin diseases, wasting syndrome, water-electrolyte imbalance; pharmaceutical preparations for the treatment of musculoskeletal system, namely, connective tissue diseases, cartilage injuries; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Parkinson's disease, tauopathies, Alzheimer's disease, frontotemporal dementias, acute injury such as traumatic brain injury, stroke, chronic neuroinflammation, epilepsy, transverse myelitis, neuromyelitis optica, leukodystrophies, multiple sclerosis, acute injury, cerebral palsy, Hirschsprung's disease, diabetic gastroparesis, glioblastoma, ALS, back pain, Bell's palsy, birth defects of the brain and spinal cord, brain aneurysm, brain tumor, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, Guillain-Barré syndrome, headache, migraine, neuralgia, neuromuscular and related diseases, neuropathy, spinal deformity, spine tumor, vertigo; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorder, depression, eating disorders, obsessive-compulsive disorder, panic disorder, personality disorders, post-traumatic stress disorder, psychotic disorders; pharmaceutical preparations for the treatment of sensory neural diseases and disorders, namely macular degeneration, glaucoma, diabetic retinopathy, auditory processing disorder, auditory verbal agnosia, neuropathic pain, hyperalgesia, phantom limb syndrome, nociceptor disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic disease; pharmaceutical preparations for the treatment of fungal skin infections and viral skin infections; biological preparations for the treatment of liver, gall bladder, pancreas, gastrointestinal, menopausal, autoimmune, ophthalmologic, renal, aural, respiratory, hematologic, diseases and disorders; biological preparation for the treatment of cardiovascular diseases and disorders, namely congestive heart failure, acute myocardial infarction, arrythmia, hypoplastic left heart syndrome, atrial fibrillation, peripheral artery disease, pulmonary arterial hypertension; biological preparations for the treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system and peripheral nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders; biological preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; biological preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immune response to grafts and transplants, autoimmune disorders, fibrosis disorders, Crohn's, Colitis, lupus, erythematosus (SLE), multiple sclerosis, neuromyelitis optica, type-1 diabetes, solid organ transplant, immunologic deficiency syndromes; biological preparations for the treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, erosion, ulcer, trauma, burned skin, pain, inflammation, contagious skin diseases, dandruff, herpes, hives, hyperhidrosis, keloids, melanoma, rosacea, scleroderma, shingles, skin cancer, warts; biological preparations for the treatment of infectious diseases, namely respiratory infections, asthma, bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema, lung cancer, pleural effusion, pneumonia, pulmonary fibrosis and sarcoidosis; biological preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, chickenpox, common cold, diphtheria, E. coli, Giardiasis, HIV/AIDS, infectious mononucleosis, influenza, Lyme disease, malaria, measles, meningitis, mumps, poliomyelitis, rocky mountain spotted fever, rubella, salmonella, severe acute respiratory syndrome (SARS), sexually transmitted diseases, shingles, tetanus, toxic shock syndrome, tuberculosis, viral hepatitis, West Nile virus, whooping cough; biological preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, lysosomal storage disorders, osteoarthritis, muscular dystrophy, anemia, acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repairdeficiency disorders, glucose metabolism disorders, hyperlactatemia, iron metabolism disorders, lipid metabolism disorders, malabsorption syndromes, metabolic syndrome X, inborn error of metabolism, mitochondrial diseases, phosphorus metabolism disorders, porphyrias, proteostasis deficiencies, metabolic skin diseases, wasting syndrome, water-electrolyte imbalance; biological preparations for the treatment of musculoskeletal system, namely, connective tissue diseases, cartilage injuries; biological preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Parkinson's disease, tauopathies, Alzheimer's disease, frontotemporal dementias, acute injury such as traumatic brain injury, stroke, chronic neuroinflammation, epilepsy, transverse myelitis, neuromyelitis optica, leukodystrophies, multiple sclerosis, acute injury, cerebral palsy, Hirschsprung's disease, diabetic gastroparesis, glioblastoma, ALS, back pain, Bell's palsy, birth defects of the brain and spinal cord, brain aneurysm, brain tumor, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, Guillain-Barré syndrome, headache, migraine, neuralgia, neuromuscular and related diseases, neuropathy, spinal deformity, spine tumor, vertigo; biological preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorder, depression, eating disorders, obsessive-compulsive disorder, panic disorder, personality disorders, post-traumatic stress disorder, psychotic disorders; biological preparations for the treatment of sensory neural diseases and disorders, namely macular degeneration, glaucoma, diabetic retinopathy, auditory processing disorder, auditory verbal agnosia, neuropathic pain, hyperalgesia, phantom limb syndrome, nociceptor disorders; biological preparations for the treatment of urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic disease; pharmaceutical preparations for the treatment of fungal skin infections and viral skin infections; biological preparations for the treatment of fungal skin infections and viral skin infections; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of liver, gall bladder, pancreas, gastrointestinal, menopausal, autoimmune, ophthalmologic, renal, aural, respiratory, hematologic, diseases and disorders; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system and peripheral nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of the endocrine system, namely growth and thyroid disorders; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of immunologic diseases, namely, autoimmune diseases, immune response to grafts and transplants, autoimmune disorders, fibrosis disorders, Crohn's, Colitis, lupus, erythematosus (SLE), multiple sclerosis, neuromyelitis optica, type-1 diabetes, solid organ transplant, immunologic deficiency syndromes; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, erosion, ulcer, trauma, burned skin, pain, inflammation, contagious skin diseases, dandruff, herpes, hives, hyperhidrosis, keloids, melanoma, rosacea, scleroderma, shingles, skin cancer, warts; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of infectious diseases, namely respiratory infections asthma, bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema, lung cancer, pleural effusion, pneumonia, pulmonary fibrosis and sarcoidosis; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, chickenpox, common cold, diphtheria, E. coli, Giardiasis, HIV/AIDS, infectious mononucleosis, influenza, Lyme disease, malaria, measles, meningitis, mumps, poliomyelitis, rocky mountain spotted fever, rubella, salmonella, severe acute respiratory syndrome (SARS), sexually transmitted diseases, shingles, tetanus, toxic shock syndrome, tuberculosis, viral hepatitis, West Nile virus, whooping cough; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, lysosomal storage disorders, osteoarthritis, muscular dystrophy, anemia, acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repairdeficiency disorders, glucose metabolism disorders, hyperlactatemia, iron metabolism disorders, lipid metabolism disorders, malabsorption syndromes, metabolic syndrome X, inborn error of metabolism, mitochondrial diseases, phosphorus metabolism disorders, porphyrias, proteostasis deficiencies, metabolic skin diseases, wasting syndrome, water-electrolyte imbalance; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of musculoskeletal system, namely, connective tissue diseases, cartilage injuries; Gene therapy products for neurological disorders, namely, pharmaceutical preparations for use in therapeutics for the treatment of brain injury, spinal cord injury, seizure disorders, Parkinson's disease, tauopathies, Alzheimer's disease, frontotemporal dementias, acute injury such as traumatic brain injury, stroke, chronic neuroinflammation, epilepsy, transverse myelitis, neuromyelitis optica, leukodystrophies, multiple sclerosis, acute injury, cerebral palsy, Hirschsprung's disease, diabetic gastroparesis, glioblastoma, ALS, back pain, Bell's palsy, birth defects of the brain and spinal cord, brain aneurysm, brain tumor, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, Guillain-Barré syndrome, headache, migraine, neuralgia, neuromuscular and related diseases, neuropathy, spinal deformity, spine tumor, vertigo; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of psychiatric diseases, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorder, depression, eating disorders, obsessive-compulsive disorder, panic disorder, personality disorders, post-traumatic stress disorder, psychotic disorders; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of sensory neural diseases and disorders, namely macular degeneration, glaucoma, diabetic retinopathy, auditory processing disorder, auditory verbal agnosia, neuropathic pain, hyperalgesia, phantom limb syndrome, nociceptor disorders; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic disease; Gene therapy products, namely, pharmaceutical preparations for use in therapeutics for the treatment of fungal skin infections and viral skin infections;

Classification kind code

11

Class [040]
Manufacturing services for others in the field of pharmaceuticals

Classification kind code

11

Class [042]
Scientific and industrial research in the fields of biochemistry and diagnostics, namely, research of new products for others, and pharmaceutical research; biochemical and pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; Research and development of human therapeutics using gene editing

Classification kind code

11

Class [044]
Providing medical information in the field of biochemistry, diagnostics and pharmaceuticals, namely, providing information relating to physical examinations and the preparation of dispensing of medications; providing medical information in the fields of biochemistry, diagnostics and pharmaceuticals via a website; providing medical information, consultancy and advisory services in the field of biochemistry, diagnostics and pharmaceuticals, namely, providing information relating to physical examinations and the preparation of dispensing of medications; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information about investigational medical devices, namely needle, cannula, catheter, bendable needle, bendable cannula, branched needle, branched cannula, MRI-guided needle, MRI-guided cannula, probe, MRI-guided catheter, injector, needle micro-injector, stereotactic instruments, stereotactic instrumentation, syringe, cell delivery matrix, cell delivery medium, gel, shearthinning, medical diagnostics services and drugs via a website; Gene therapy for the treatment of cardiovascular diseases and disorders, namely congestive heart failure, acute myocardial infarction, arrythmia, hypoplastic left heart syndrome, atrial fibrillation, peripheral artery disease, pulmonary arterial hypertension

Classification kind code

11

Mark Details

Serial Number

1854001

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 17th May 2021		Approved
Submitted for opposition 12
on 15th Jul 2020		Extension of Time
Submitted for opposition 135
on 9th Jun 2020		Amendment to Application
Submitted for opposition 15
on 7th Jan 2020		Correspondence Created
Submitted for opposition 12
on 30th Apr 2019		Extension of Time
Submitted for opposition 22
on 4th Oct 2018		Search Recorded
Submitted for opposition 20
on 4th Oct 2018		Examiner's First Report
Submitted for opposition 31
on 25th Aug 2017		Formalized
Submitted for opposition 1
on 24th Aug 2017		Created
Submitted for opposition 30
on 23rd Aug 2017		Filed